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Abstract
Background: Advances in peri-operative care of surgical oncology patients result in shorter hospital stays. Earlier
discharge may bring benefits, but complications can occur while patients are recovering at home. Electronic patient-
reported outcome (ePRO) systems may enhance remote, real-time symptom monitoring and detection of complications
after hospital discharge, thereby improving patient safety and outcomes. Evidence of the effectiveness of ePRO systems in
surgical oncology is lacking. This pilot study evaluated the feasibility of a real-time electronic symptom monitoring system
for patients after discharge following cancer-related upper gastrointestinal surgery.
Methods: A pilot study in two UK hospitals included patients who had undergone cancer-related upper gastrointestinal
surgery. Participants completed the ePRO symptom-report at discharge, twice in the first week and weekly post-
discharge. Symptom-report completeness, system actions, barriers to using the ePRO system and technical performance
were examined. The ePRO surgery system is an online symptom-report that allows clinicians to view patient symptom-
reports within hospital electronic health records and was developed as part of the eRAPID project. Clinically derived
algorithms provide patients with tailored self-management advice, prompts to contact a clinician or automated clinician
alerts depending on symptom severity. Interviews with participants and clinicians determined the acceptability of the
ePRO system to support patients and their clinical management during recovery.
Results: Ninety-one patients were approached, of which 40 consented to participate (27 male, mean age 64 years).
Symptom-report response rates were high (range 63–100%). Of 197 ePRO completions analysed, 76 (39%) triggered self-
management advice, 72 (36%) trigged advice to contact a clinician, 9 (5%) triggered a clinician alert and 40 (20%) did not
require advice. Participants found the ePRO system reassuring, providing timely information and advice relevant to
supporting their recovery. Clinicians regarded the system as a useful adjunct to usual care, by signposting patients to seek
appropriate help and enhancing their understanding of patients’ experiences during recovery.
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Conclusion: Use of the ePRO system for the real-time, remote monitoring of symptoms in patients recovering from
cancer-related upper gastrointestinal surgery is feasible and acceptable. A definitive randomised controlled trial is needed
to evaluate the impact of the system on patients’ wellbeing after hospital discharge.
Keywords: Adverse events, Pilot studies, Patient-reported outcomes, Electronic health record, Internet, Cancer,
gastrointestinal, Gastrointestinal surgical procedures, Self-management
Background
Major abdominal surgery for upper gastrointestinal
(UGI) cancer is a significant life event with a hospital
stay of usually more than a week and a high risk of com-
plications. For example, up to 5% of patients die within
30 days of surgical resection for oesophageal cancer. As
many as 30–45% of UGI, hepatobiliary and cancer sur-
gery patients require community care or experience
complications post-discharge [1–3], including wound in-
fections, sepsis and respiratory failure [4–7] requiring
hospital treatment. Recovery from surgery for these pro-
cedures often takes many months. Symptoms such as fa-
tigue, nausea and pain are frequent and severe [2], and
patients report significant deficits to many aspects of
their health-related quality of life (HRQL), including
marked reductions in physical, social and role function
[8, 9].
Advances in Enhanced Recovery After Surgery (ERAS)
protocols mean that patients are increasingly discharged
from hospital sooner. While earlier discharge may be
feasible and safe [10–12], shorter hospital stays are asso-
ciated with reductions in the provision of patient infor-
mation and symptom self-management advice [13]. As a
result, patients recovering at home may experience un-
satisfactory pain management and increased anxiety
[13]. Furthermore, ERAS protocols are not standardised
and do not routinely encompass the post-discharge re-
covery period, meaning that follow-up care is often frag-
mented [13, 14]. Patients may be followed-up through
telephone calls from nurse specialists, but this practice is
likely to vary between hospitals. Once at home, detection
of problems and complications relies on the patient’s
ability to distinguish between expected and concerning
symptoms and to access appropriate clinical services.
However, patients may be uncertain about when to con-
tact a health professional outside of routine clinical ap-
pointments, which can delay them seeking help [15, 16].
Late detection of complications after discharge can lead
to poor outcomes, impaired HRQL and increased emer-
gency department admissions [17].
Incorporating patient-reported outcome (PRO) mea-
sures into routine clinical practice has been shown to
enhance symptom monitoring and the detection of com-
plications in cancer patients [18, 19]. Electronic plat-
forms to collect PROs (ePRO) are an efficient means of
capturing PRO data after patients have left hospital. Spe-
cifically, ePRO systems that use clinically-derived algo-
rithms to interpret patient-reported symptom data in
the context of their clinical characteristics (e.g. disease
stage, surgical procedure, recovery pathway) may provide
patients with pertinent self-management advice to sup-
port their recovery [20–23]. For optimal performance,
full integration of ePROs with electronic hospital records
(EHR) and clinical information systems can also provide
clinicians with access to ‘real-time’ ePRO data. This en-
ables prompt clinical intervention [24, 25] and allows cli-
nicians to consider patient-reported symptoms alongside
other clinical data to optimally plan appropriate care.
This has been shown to enhance quality of care and
communication [26, 27] and improve patients’ satisfac-
tion with care [18].
Several ePRO systems, developed for patients undergo-
ing chemotherapy [22, 28–32], have been shown to im-
prove HRQL [22, 29–31, 33] and survival [29]. Few
studies, however, have evaluated the effectiveness of
ePRO systems in patients undergoing surgery for cancer.
The aim of this pilot study was to examine the feasibility
of a full-scale definitive randomised controlled trial
(RCT) designed to evaluate the impact of a real-time, re-
mote electronic monitoring (ePRO) system on patients’
wellbeing after discharge following cancer-related UGI
surgery.
Specific study objectives were to: (i) explore partici-
pant eligibility and recruitment; (ii) examine participant
ePRO symptom-report response rates and data com-
pleteness; (iii) examine the frequency of patient-reported
symptoms and ePRO system actions; (iv) explore patient
and clinician perspectives on using the ePRO system; (v)
evaluate the technical performance of the ePRO system;
(vi) pilot potential outcome measures for use in a future
main trial.
Methods
Development of the ePRO surgery system
The ePRO surgery system was developed initially in the
example context of cancer-related UGI surgery. The sys-
tem was developed in close collaboration with multiple
key stakeholder groups, including patients, patient repre-
sentatives and health care professionals (HCPs) (i.e. can-
cer nurse specialists (CNS), dietitians and surgeons)
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responsible for routine’ post-discharge care. The devel-
opment of the ePRO system and the electronic hosting
platform has been described in full elsewhere [34–36].
The IT elements, developed in the eRAPID study [36],
include a patient website with secure login function,
web-based symptom-report questionnaire software
(QTool) and a web application interface for secure trans-
fer of data to EHR, enabling clinicians to view symptom-
reports. Clinically-derived algorithms were programmed
into the self-report scoring system, allowing severity spe-
cific tailored self-management advice to be provided to
patients and email notifications sent to nominated
clinicians.
ePRO system clinically derived algorithms to guide
patient management by symptom severity
The system uses clinically derived algorithms to stratify
patients’ ePRO symptom-report responses into three
levels of symptom severity with each triggering a differ-
ent ‘level’ of action within the ePRO system (Table 1),
and is described in detail elsewhere [34]. For symptoms
indicative of a complication, an email alert is sent to the
CNS team. For potentially concerning symptoms, partic-
ipants are advised to call an HCP. For expected symp-
toms, the ePRO system provides participants with self-
management advice. The ePRO symptom-report com-
prised 35 questions selected from validated European
Organisation for Research and Treatment of Cancer
(EORTC) questionnaires. Items were selected for their
relevance to symptoms and complications experienced
by patients after cancer-related UGI surgery (including
oesophageal, gastric and hepato-pancreato biliary can-
cer) [34] and focus on severity in the preceding week
(e.g. During the past week, have you had pain? Possible
responses are: not at all; a little; quite a bit or very
much). Symptom domains included EORTC domains
physical function, nausea, vomiting, eating and digestive
problems, jaundice, fever and pain [34]. Graphs display-
ing scores for each symptom are produced within the
ePRO system, enabling patients and clinicians to moni-
tor symptom occurrence and severity over the course of
patients’ recovery. Following their development, refine-
ment and testing of the algorithms triggering the ePRO
system feedback and alerts was also undertaken as part
of earlier work [34]. Specifically, questionnaire data from
27 participants (18 male, mean age 63 years) who re-
ported clinically significant symptoms was compared,
firstly, with advice provided by a CNS or study research
nurse during audio-recorded routine telephone consulta-
tions and weekly telephone interviews and, secondly,
with any subsequent clinical events or outcomes of par-
ticipants (e.g. such as re-intervention, re-admission to
hospital, visit to GP or primary healthcare providers).
The latter were identified from hospital readmission
alerts, hospital EHR, and patients’ reports of accessing
healthcare services reported during weekly follow-up
telephone interviews. Refinement and iteration of the al-
gorithms continued until it was considered that no fur-
ther changes were required.
Design and setting
This mixed methods prospective pilot study was con-
ducted at two National Health Service (NHS) hospital
trusts in England. Feasibility of the fully functional ePRO
system accessible via EHRs was examined at Bristol
Royal Infirmary, University Hospitals Bristol NHS Foun-
dation Trust (Centre 1). Integration of electronic moni-
toring systems into hospital EHRs can be problematic
and the extent of integration variable. As such, the feasi-
bility and applicability of the system at a second site
(Heartlands Hospital, University Hospitals Birmingham,
Centre 2) where integration was not possible was ex-
plored. In the version of the ePRO system tested at
Centre 2, clinicians could not access patients’ symptom-
reports via EHRs. Data from Centre 2 were therefore
analysed separately, with a focus on examining partici-
pant recruitment, ePRO symptom-report response rates
and data completeness. Consecutive patients at both
centres were recruited and invited to complete online
symptom-reports at the point of hospital discharge,
twice in the first week post-discharge and weekly for 8
weeks thereafter. Recruitment rates, online symptom-
Table 1 Guided patient management by symptom severity within the ePRO system
Symptom severity level ePRO system action/advice Example of ePRO action/advice for shortness of breath
Level 0: minimal/no symptoms No patient advice required Thank you for completing the questionnaire.
Level 1: expected symptom(s) Patient advice: self-management advice Some shortness of breath after physical activity such as climbing
the stairs is a normal part of recovery. You may wish to consider
the advice below…
Level 2: potentially concerning
symptom(s)
Patient advice: contact a healthcare professional
today if symptom is new or unreported
If you have not already discussed your shortness of breath with
your medical team we recommend that you contact your CNS
team today to discuss your symptoms
Level 3: symptom(s) indicative of
a complication
(i) Patient advice: contact a healthcare
professional immediately
(ii) Clinician alert: automated email to a
Cancer Nurse Specialist
We recommend that you contact the hospital now to discuss
your symptoms with the medical team. If you are unable to
contact the CNS team, please call your GP to discuss your
symptoms today
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report completion rates and activation of clinical algo-
rithms were monitored. Patients were interviewed
weekly and additional outcomes related to health status
were collected on paper. The CNS teams at both centres
received Level 3 alerts via automatic emails, and in
Centre 1 the lead CNS was interviewed weekly.
Participant sampling and recruitment
Consecutive patients who had undergone cancer-related
UGI surgery (including oesophageal, gastric or hepato-
pancreato biliary cancer) at Centre 1 between August
2017 and March 2018 and Centre 2 between November
2017 and October 2018 were screened for study eligibil-
ity by a hospital research nurse reviewing inpatient clinic
lists. Patients were considered eligible if they had under-
gone cancer-related UGI surgery, were ready for hospital
discharge to their home, had access to a computer/mo-
bile device and the internet at home, were 18 or over
and were fluent in English. Patients were approached for
recruitment by a research nurse immediately prior to
hospital discharge (e.g. while on the hospital ward). Eli-
gible patients were given a participant information leaflet
and the opportunity to ask questions, and those wishing
to participate were asked to provide written informed
consent. Demographic and clinical details were recorded.
Participants were provided with unique login details and
use of the ePRO system was demonstrated by the re-
search nurse, during which participants completed the
baseline (pre-discharge) ePRO symptom-report and
paper version of the additional measures (e.g. EQ-5D
and Fact-G).
Data collection
Recruitment, response rates and data completeness were
recorded. An overview of data collected at assessment
timepoints at each site is provided in Table 2.
Participant eligibility and recruitment
Screening logs were completed to examine the number
of participants eligible, approached, recruited and with-
drawn from the study. Rates and reasons for non-
eligibility, declining participation and participant with-
drawal were monitored.
ePRO symptom-report response rates and data
completeness
Participants were instructed to complete the online
ePRO symptom-report twice in the first week post-
discharge (day two-three and day five-seven) and then
weekly for 8 weeks. These timepoints were selected to
reflect clinically relevant timepoints for monitoring of
patients during their recovery post-discharge following
Table 2 Data collection at baseline and post-discharge assessment timepoints
Point of
discharge
Post-discharge
Baseline 2–3
days
5–7
days
Week 2 Week 3 Week 4 Week 5 Week 6 Week 7 Week 8 Post-
study
End of
study
interviews
Screening log completion
(Centre 1 only)
✓
Participant demographic
and clinical characteristics
✓
ePRO questionnaire
completion
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
FACT-G & EQ-5D
questionnairesa
✓ ✓ ✓
Weekly follow-up
participant interviews
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
Health resource use
questionnaireb
✓
End of study participant
interviews (10% participants)
✓
Weekly follow-up clinician
interviews (Centre 1 only)
✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓ ✓
End of study clinician
interviews (Centre 1 only)
✓
Abbreviations: ePRO electronic patient-reported outcome, FACT-G Functional Assessment in Cancer Therapy Scale – General
aThe FACT-G is a standardised cancer specific health related quality of life measure. The EQ-5D is a standardised measure of health status used in clinical and
economic evaluation. These measures were administered in paper format
bThe health resource use questionnaire included items to record use of prescription and non-prescription medication and other costs associated with patients’
recovery from surgery. These measures were administered in paper format
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UGI surgery [34]. However, participants were told that
they could complete the symptom-report at additional
timepoints if they wished (e.g. if they experienced new
symptoms). Automated reminders (by text message and/
or email depending on participants’ preferences) were
sent when participants were due to complete the ePRO
symptom-report.
Frequency of reported symptoms and ePRO system actions
In order to determine the suitability of the actions and
advice generated by the ePRO system, the frequency, se-
verity and type of reported symptoms and actions gener-
ated at each timepoint were examined.
Patient and clinician perspectives
Participant interviews Members of the research team
(AP, HR, MS) conducted weekly semi-structured tele-
phone interviews with participants to coincide with
ePRO symptom-report timepoints, generally shortly after
questionnaire completion. Interviews focused on partici-
pants’ views of using the ePRO system and any re-
sponses they had had to ePRO system actions. For
example, if a participant reported a potentially concern-
ing symptom that had generated a Level 2 action, the
patient was asked whether they had contacted an HCP
as advised, and any subsequent outcomes resulting from
such HCP contact were documented. The purpose of
the weekly and end of study interviews was not to dis-
cuss patients’ symptoms or provide advice regarding
managing or seeking treatment for problematic symp-
toms. Instead, the interviews were undertaken to exam-
ine participants’ perspectives on the usefulness of the
ePRO system and feedback from the perspective of
examining the feasibility and usability of the system. The
interview guides were adapted from pilot work to de-
velop the ePRO system [34] and are provided in Add-
itional file 1. Reasons for not adhering to ePRO system
actions/advice were also recorded. Participants generat-
ing Level 1 self-management advice for expected symp-
toms were asked for their views on the advice and its
relevance and usefulness. A purposive sample of ap-
proximately 10%, to include patients who reported a
range of clinical symptoms, were also interviewed at the
end of the study to explore their experiences of using
the ePRO system. All interviews were audio-recorded.
Hospital readmissions Clinical data were collected
from hospital EHR for Centre 1 participants who had
been readmitted to hospital with complications during
their recovery. These data were compared with interview
data to establish whether participants had completed a
corresponding symptom-report and any actions that
may have been generated.
Clinician interviews The lead CNS in Centre 1 was
interviewed weekly by telephone by a study researcher
(HR) to determine the frequency, nature and relevance
of any clinical contact they had received from partici-
pants as a direct result of ePRO system actions. End-of-
study interviews were also conducted with the lead CNS
and the hospital dietitian responsible for the care of par-
ticipants. These explored the practicality and usefulness
of the ePRO system in the context of routine clinical
care.
Technical performance
Technical functionality of the ePRO system was moni-
tored throughout the study, including integration with
EHR, failed logins and delivery of email clinician alerts
and participant text/email reminders.
Piloting of potential outcome measures for a main trial
Participants were mailed paper copies of the EuroQol
EQ-5D-5 L [37] and Functional Assessment of Cancer
Therapy – General (FACT-G) [38] questionnaires to
complete at baseline (pre-discharge) and at weeks four
and eight post-discharge. The EQ-5D-5 L is a standar-
dised, validated measure of health status that is used in
the clinical and economic evaluation of healthcare and
population health surveys. It provides a single index
value and descriptive profile that contributes to a health
economic evaluation across five dimensions: mobility,
self-care, usual activities, pain/discomfort and anxiety/
depression. The five response levels range from ‘no
problems’ to ‘extreme problems’. The EQ-5D also in-
cludes a visual analogue scale relating to subjective over-
all health status. The FACT-G is a cancer specific
measure that is widely used in research studies, measur-
ing four domains of HRQL: physical wellbeing, social or
family wellbeing, emotional wellbeing and functional
wellbeing. Cumulative scores range from 0 to 108 with
higher scores indicating better HRQL. Questionnaire re-
sponse rates and data completeness were examined to
explore their feasibility for use as potential outcome
measures in a future RCT.
Methods for collecting health resource use data were
explored. Patients were asked to complete a health re-
source use questionnaire [35] at the end of the study (9
weeks post-discharge). The questionnaire included items
to record use of prescription and non-prescription medi-
cation and other costs associated with patients’ recovery
from surgery. Patients were also contacted weekly by the
study researcher to record the frequency and reasons for
contact with HCPs (e.g. general practitioner (GP), com-
munity nurse, etc).
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Data analyses
Summary descriptive statistics were used to examine par-
ticipant screening, recruitment, demographic and clinical
characteristics. Symptom-report response rates, data com-
pleteness and reasons for non-completion were sum-
marised. Descriptive statistics also summarised symptom-
report response rates and data completeness, frequency
and severity of symptoms reported and any actions gener-
ated. Audio-recordings of interviews with participants and
clinicians were listened to by a researcher (HR) and those
containing data of relevance to the study objectives were
transcribed verbatim (targeted transcription). Textual data
were analysed in accordance with the principles of the-
matic analysis [39], in which codes were generated and ap-
plied to sections of text. Codes were reviewed and refined
through discussion with the study team. Thematic analysis
is a widely-used methods of qualitative analysis involving
the identification and interpretation of underlying themes
and concepts within the wider context of the data. The
interview topic guide was iterated following discussion
with the study team as data collection and participant re-
cruitment proceeded. Analysis was conducted until the-
matic saturation was reached, whereby existing themes
ceased to evolve and no new themes were identified [40].
Here we report the main themes within the context of a
wider mixed methods study.
Results
Participant eligibility and recruitment
One hundred and nine patients were screened for eligibility
at Centre 1, of which 41 (38%) were eligible and invited to
participate, and 29 (71%) consented. (Fig. 1). Patients who
agreed to take part were similar to those who declined in
terms of demographics (participants: 66% male, refusers:
50% male) or age (participants: mean age 64, range 43–81
years, refusers: mean age 59, range 30–74 years). Reasons
for ineligibility included participants not undergoing their
planned surgical procedure (17, 25%), having no home ac-
cess to a computer/mobile device or internet (15, 22%) (Fig.
1). Seven (24%) Centre 1 participants withdrew from the
study due to feeling too tired or unwell or a prolonged re-
admission to hospital. Approximately half (n = 15, 52%) of
patients had undergone oesophago-gastric resection proce-
dures, with an average hospital stay of 12 days. Participant
demographic details are provided in Table 3. In Centre 2,
20 patients were screened for eligibility, of which 11 con-
sented to participate. All 11 participants had undergone
oesophago-gastric resection procedures (Table 3). Two
(18%) Centre 2 participants withdrew from the study.
ePRO symptom-report response rates and data
completeness
Response rates of active participants (i.e. participants
who had not withdrawn from the study) in Centre 1 for
the ePRO symptom-report exceeded 70% at all time-
points (range 72–93%), excluding day two-three post-
discharge (55%). Between 30/08/2017 and 17/04/2018,
29 participants completed the ePRO symptom-report a
total of 197 times (median 9, range = 1–11). Most com-
mon reported reasons for non-completion included par-
ticipants starting chemotherapy (12%) and not wanting
to complete the symptom-report at that timepoint (10%)
(see Table 4). In Centre 2, ePRO symptom-report re-
sponse rates exceeded 60% at all timepoints (range 63–
100%), except for week eight (50%). Between 10/11/2017
and 22/11/2018, participants completed the ePRO
symptom-report a total of 63 times (median 7, range 1–
10). Reasons for non-completion were not recorded.
Frequency of reported symptoms and ePRO system
actions
Frequencies of symptoms reported by Centre 1 partici-
pants and associated actions triggered by the ePRO sys-
tem are shown in Table 5. Of the nine Level 3 email
alerts to clinicians, seven (78%) were generated in the
first 3 weeks following discharge from hospital (Fig. 2).
Over half (n = 43, 60%) of the 72 Level 2 actions (partici-
pant advice to call an HCP) were triggered within the
first 2 weeks post-discharge, with a further 15% (n = 11)
triggered after 6 weeks post-discharge. Most (n = 48,
63%) of the 76 Level 1 actions (self-management advice)
were triggered after 3 weeks post-discharge, the majority
of which were triggered at weeks four and five. Of the
40 forty Level 0 feedback (no participant advice re-
quired), 27 (68%) instances were triggered after 5 weeks
post-discharge.
An additional eight Level 3 alerts were generated from
the baseline data completion prior to patients being dis-
charged. These data were removed from the dataset
post-hoc following consultation with clinicians, as they
were deemed irrelevant due to patients still being in
hospital.
In Centre 2 one Level 3 alert was triggered at week
three, and 14 (70%) of the 20 Level 2 actions were trig-
gered in the first 3 weeks post-discharge. Most (n = 25,
69%) of the 36 Level 1 self-management advice were
triggered after 3 weeks post-discharge, while five (83%)
of the six Level 0 feedback (83%) were triggered after 4
weeks post-discharge.
Symptoms triggering level 3 actions (alert to CNS)
Level 3 alerts (automated email to CNS team) were trig-
gered nine times (4.6% of all completions) by a total of
three (10%) participants in Centre 1 (see Table 5). Tele-
phone interviews with participants demonstrated that
when they made direct contact with the CNS team as
instructed by the system they reported positively on
their experience:
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PT 1237: “It was great. It was reassuring…And it’s
what I need actually…I can’t just phone my GP…I’m
not even on my own GP’s list because I’ve been
transferred [to a different geographical region]
temporarily.”
Most Level 3 alerts (n = 7, 78%) were generated for pain
symptoms. Six of the seven pain alerts were from a sin-
gle participant due to a pre-existing chronic pain condi-
tion, and were therefore not related to recovery from
surgery. Weekly telephone interviews revealed that no
action was taken by the CNS team relating to these
Fig. 1 Recruitment details for Centre 1 Bristol participants. a including: not undergoing planned procedure (n = 17), discharged home
unexpectedly early or not discharged to home (n = 4), missed due to administration errors (n = 2), patient was under 18 (n = 1). b including: no
home access to a PC/internet (n = 15), discharged home unexpectedly early or not discharged to home (n = 11), not fluent in English (n = 3),
missed due to administration errors (n = 2), unable to comply with follow up (n = 3)
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alerts, as the participant was already receiving appropri-
ate treatment from another care team.
The remaining two non-pain related Level 3 alerts
were generated by a single participant reporting
symptoms of fever and chills due to a complication fol-
lowing surgery. Although an alert was generated, no fur-
ther action was taken by the participant or the CNS
team, in accordance with Level 3 advice because these
symptoms had already been treated prior to ePRO sys-
tem completion:
PT 1184: “Because I’ve been completing the form on
a Friday, if there’s been any circumstances where
I’ve needed to contact someone it’s probably been
earlier in the week and action’s already been
taken…We were already dealing with [fever
symptoms]. Probably already [contacted HCP].”
This demonstrates the need for a further minor refine-
ment to the Level 3 and 2 algorithms to ensure that er-
roneous symptoms relating to underlying health
conditions and relevant symptoms that are already being
well-managed do not trigger alerts to clinicians.
Symptoms triggering level 2 actions (advice to contact an
HCP)
In total, 72 Level 2 actions (advice to contact an HCP)
were triggered by 24 (83%) participants in Centre 1 and
were most frequently related to wound problems (44%)
and appetite loss (36%). Additional symptoms generating
Level 2 advice included fever (24%), physical function
(13%) and nausea or vomiting (11%). Figure 3 illustrates
the distribution of the most frequent symptoms generat-
ing Level 2 advice by recovery timepoint.
Of the 72 Level 2 actions triggered, corresponding
weekly telephone interview data were available for 36
(50%) of these events from 17 participants.
Adherence to level 2 action advice to contact an HCP
In most instances (23/36, 64%), participants adhered to
the Level 2 advice to only contact an HCP if their symp-
toms were new or previously unreported. In eight (35%)
cases, all participants with new symptoms followed ad-
vice to contact an HCP, of which four participants con-
tacted the CNS team and four contacted a GP.
Contacting an HCP resulted in four participants receiv-
ing advice and/or reassurance about their symptoms,
three undergoing clinical investigations or interventions
(e.g. blood tests, appointments), and one receiving a pre-
scription for antibiotics for a wound infection:
PT 1213: “The second time [called GP following
Level 2 advice] I was feeling so tired and [GP] sent
me for a blood test and found I’m low on something
and I’m on four tablets a day now.”
In 15 cases (65%), participants appropriately followed
advice not to contact an HCP because their symptoms
Table 3 Participant baseline clinical and demographic details
Centre 1
Bristol participants
(n = 29)
Centre 2
Birmingham participants
(n = 11)
Sex, n (%)
Male 19 (66) 8 (73)
Age, years
Mean (SD)a 64.2 (9.8) 63.4 (14.9)
Range 43–81 42–81
Ethnicity, n (%)
White British 22 (76) 11 (100)
Chinese 1 (3) 0
Not stated 6 (21) 0
Cancer diagnosis, n (%)
Yes 21 (72) 11 (100)
Length of hospital stay, days
Mean (SD)a 12 (9) 18 (12)
Median (IQR)b 9 (6–14) 11 (10–15)
Range 3–35 9–45
Surgical procedure received, n (%)
Oesophago-gastric
resection
15 (52) 11 (100)
Hepatobiliary resection 14 (48) 0
Marital status, n (%)
Married/civil partnership/
cohabiting
26 (91) 5 (46)
Single 1 (3) 1 (9)
Divorced/separated 1 (3) 2 (18)
Widowed 1 (3) 3 (27)
Education, n (%)
Further education 22 (76) 6 (55)
Degree/professional
qualification
15 (52) 5 (46)
Employment status, n (%)
Retired 15 (52) 6 (55)
Working full-time 6 (20) 3 (27)
Working part-time 4 (14) 1 (9)
Not in paid employment 4 (14) 1 (9)
Computer usage, n (%)
Daily 26 (90) 8 (73)
Weekly 3 (10) 1 (9)
Rarely 0 2 (18)
Proficiency with computer, n (%)
Easy 21 (72) 7 (64)
Sometimes difficult 8 (28) 2 (18)
Difficult 0 2 (18)
aStandard deviation
bInterquartile range
Richards et al. BMC Cancer          (2020) 20:543 Page 8 of 17
Table 4 Response rates and reasons for non-completion of ePRO questionnaire
Baselinea 2–3 days 5–7 days Week 2 Week 3 Week 4 Week 5 Week 6 Week 7 Week 8
Active participantsb, n 29 29 29 27 25 24 24 23 22 22
Active participants completing ePRO
questionnaire, n (%)c
27 (93) 16 (55) 23 (79) 20 (74) 21 (84) 21 (88) 22 (92) 19 (83) 16 (72) 17 (77)
Active participants not completing
ePRO questionnaire, n
2 13 6 7 4 3 2 4 6 5
Reasons for non-completion: Totals
Withdrawn from the study 0 0 2 (33) 2 (29) 1 (4) 0 1 (50) 1 (25) 0 0 7
Unknown - participant could not
be reached for weekly phone
interview
0 7 (54) 4 (67) 2 (29) 0 2 (67) 1 (50) 2 (50) 2 (33) 1 (20) 21
Did not want to 1 (50) 1 (8) 0 1 (14) 1 (4) 0 0 0 0 1 (20) 5
Started chemotherapyd 0 0 0 0 0 0 0 1 (25) 2 (33) 3 (60) 6
Admin failure (e.g. overlap of
dates/ University closure)
1 (50) 1 (8) 0 0 1 (4) 1 (33) 0 0 1 (17) 0 5
Re-admitted to hospital 0 1 (8) 0 2 (29) 0 0 0 0 0 0 3
Too busy 0 1 (8) 0 0 1 (4) 0 0 0 1 (17) 0 3
Too unwell 0 2 (15) 0 0 0 0 0 0 0 0 2
Total number of ePRO questionnaire completions 19e 18 23 21f 21 21 22 19 16 17 197
aBaseline completion takes place at the point of hospital discharge. All subsequent timepoints are length of time since hospital discharge
b Participants who had not withdrawn from the study
cThe design of the ePRO system ensures all items are completed, except for completions that were abandoned prior to submission
d Patients halted completion of ePRO if they commenced chemotherapy during follow-up
e 8 baseline completions triggering a Level 3 action were removed from the dataset post-hoc because they were later determined to be clinically irrelevant by
participants and clinicians (as they were retrospectively reporting symptoms experienced immediately post-surgery that had resolved). This will inform the next
iteration of algorithms to be using in a full RCT
f The ePRO system allows multiple completions at each timepoint
Table 5 Frequency of reported symptoms and ePRO system actions by patients at Centre 1 (n = 29)
ePRO system reported symptoms
and actions.
Number of times (%) symptom
triggered action (n = 197)
Number (%) of patients triggering
actions at any timepoints (n = 29)
Level 3 action – alert to CNS a 9 (4.6) 3 (10.3)
Pain 7 (3.6) 2 (6.9)
Fever and chills 2 (1.0) 1 (3.4)
Level 2 action - advice to contact HCP a 72 (36.5) 24 (82.8)
Wound problems 32 (16.2) 14 (48.3)
Appetite loss 26 (13.2) 12 (41.3)
Fever and chills 18 (9.1) 6 (20.7)
Physical function 10 (5.1) 8 (27.6)
Nausea and vomiting 8 (4.1) 8 (27.6)
Shortness of breath 7 (3.6) 5 (17.2)
Level 1 action - symptom advice b 76 (38.6) 22 (75.9)
Fatigue 58 (29.4) 20 (70.0)
Pain 27 (13.7) 12 (41.3)
Physical function 22 (11.2) 10 (34.5)
Constipation 20 (10.2) 10 (34.5)
Nausea and vomiting 20 (10.2) 8 (27.6)
Reflux 17 (8.6) 8 (27.6)
Level 0 (minimal/no symptoms) - No advice required 40 (20.3) 9 (31.0)
a Level 2 and 3 actions can be triggered by the reporting of multiple symptoms
b If more than 6 symptoms reached Level 1 threshold, only the top 6 symptoms (ranked a priori by healthcare professionals) were listed with symptom-specific
advice at completion of ePRO
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were already being appropriately managed and/or they
had upcoming clinical appointments:
PT 1205: “I was already in contact with people
about [symptoms], so the questionnaire told me to
do that anyway, but I was already doing it. Had I
not been doing it, it would have helped me, but I
was doing it anyway.”
Participants described how receiving advice to contact
an HCP was reassuring, as until that point they had been
uncertain whether their symptoms required clinical in-
put or further intervention:
PT 1242: “I’ve been thinking, should I ring the nurse
about constipation or should I not?...Sometimes you
feel you shouldn’t ring your nurse, you know. Silly
really because that’s what the nurse is there for isn’t
it.”
Non-adherence to level 2 action advice to contact an
HCP Of the 13 (36%) instances when participants did
not adhere to Level 2 advice, reasons for not contacting
an HCP included feeling that their symptoms did not
warrant reporting (n = 6), for example, because they
already had an HCP appointment scheduled:
PT 1224: “It [ePRO] said that I’ve been having
problems with my wound, and it said that I ought to
see somebody within 48 hours. Well as I had an
appointment…this morning at [the hospital] I didn’t
see any need to call anybody.”
Other reasons included participants forgetting that they
had received the Level 2 advice (n = 6, 46%), or stating
an unwillingness to contact an HCP (n = 1).
Symptoms triggering level 1 symptom (self-management
advice)
Level 1 self-management advice was triggered a total of
76 times (39% of completions) by 22 (76%) participants
in Centre 1 post-discharge. Typically, advice was pro-
vided for three symptoms (median = 2.5, range = 1–6)
per Level 1 action triggered. Advice was generated most
frequently for fatigue (n = 58) and/or pain (n = 27). Add-
itional symptoms generating Level 1 advice included
physical function (n = 22), nausea or vomiting (n = 20)
and constipation (n = 20). Figure 4 illustrates the fre-
quency and distribution of the six most frequent symp-
toms triggering Level 1 advice at each timepoint.
Level 0 feedback for minimal symptoms (no action
required)
Level 0 feedback was generated a total of 40 times (20%
of completions) by approximately one third of partici-
pants in Centre 1 (n = 9, 31%) (Fig. 2).
Hospital re-admissions
Five participants were re-admitted to hospital during the
study for complications relating to fevers/infections (n = 3),
nausea & vomiting (n = 1) and bile leak (n = 1). These par-
ticipants completed the ePRO symptom-report a total of 14
times within 7 days of re-admissions. These completions
resulted in two Level 3 events (14%), nine Level 2 events
(64%) and one Level 1 event (7%), indicating that, in the
majority of instances, the ePRO system produced appropri-
ate advice based on complication-related symptoms re-
ported by patients. While it is not possible to provide exact
numbers, there were several instances where participants
were re-admitted to hospital for complications related to
post-operative infections without having completed the
ePRO system. In these instances, participants recognised
the severity of their symptoms and contacted the care team
Fig. 2 Total levels of feedback generated by timepoint
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without the need for prompting from voluntary completion
of the ePRO system.
Patient and clinician perspectives
Participant interviews
One hundred and nine (63%) of a potential 173 weekly
telephone interviews were completed. All 29 participants
were interviewed at least once following discharge. The
main reasons for non-completion were participants be-
ing unavailable or non-contactable. The key themes
identified from targeted transcriptions of 35 weekly tele-
phone interviews and three end-of-study interviews with
16 participants are reported below.
Reassurance from ePRO system advice Most partici-
pants reported positively on their experience of using
the ePRO system. Participants described how they
found the Level 1 symptom self-management advice
to be valuable because it provided reassurance about
how to manage their symptoms while at home. Par-
ticipants cited the benefit of receiving confirmation
that their symptoms were typical for their stage of re-
covery as the main reason for finding the ePRO sys-
tem reassuring:
PT 1230: “It’s all about a bit of reassurance really.
The minute you get a bit of reassurance, everything
else seems a bit easier.”
PT 1242: “The system’s good at telling you what’s
normal, or not even normal, but that other people
have this [experience of symptoms].”
Additionally, participants valued being provided with
new symptom management advice to help them better
manage their own symptoms:
PT 1182: “Things like not drinking too much coffee
tea and alcohol, which I hadn’t thought of before, I
didn’t think that would affect the issue but
apparently it does, so I’ll abide by that advice.”
Some participants acknowledged that the advice pro-
vided by the ePRO system was similar to advice they had
originally received from their care teams. Participants
found the ePRO system advice useful for reminding
them to follow advice they may have forgotten and rein-
forced the guidance they had received from HCPs:
PT 1226: “[The same advice] had been mentioned
earlier on in the process, I think when I had my
initial consultation…and it just reminded me of all
those things…And I found them very useful, although
they weren’t adding anything new, again they were
reassuring.”
Participants also stated that the reassurance they gained
from the ePRO system contributed to overcoming feel-
ings of isolation and uncertainty following discharge
from hospital:
PT 1188: “I mean you get monitored so much in the
hospital…And then you come out and there’s nothing
at all. It’s like a sudden drop off a cliff really. And
your first week and that you go well, am I OK? You
know they’ve been checking for all this time.”
Participants discussed the graphs produced by the ePRO
system, which displayed their individual symptom-report
scores over the course of the study and described these as
useful for tracking their progress over time. Participants
spoke about the reassurance they gained from being able
to objectively see that their symptoms were improving:
Fig. 3 Frequency of Level 2 Advice generated by timepoint. 1Higher scores indicate worse symptoms. 2Higher scores in physical function indicate
better physical function
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PT 1205: “It was telling me that I was getting better
I think, which is what I was hoping for. That was
quite informative I thought, looking at the graphs at
the end, that was quite good.”
Relevance of ePRO advice Participants discussed ePRO
advice as being relevant to their symptoms and address-
ing their concerns about symptom management. For
many participants the advice generated accurately
reflected their symptom experiences:
PT 1182: “I think it covered the two main [symp-
toms] that I was bothered about.”
Participants described the benefit of receiving relevant
symptom self-management advice tailored specifically to
them and found this helpful:
PT 1208: “At the end you get to read up about what
the suggestions are to cope with the different things I
might have raised and that’s always very helpful…
and aimed specifically at me.”
Clinician interviews
The majority of ePRO-initiated clinician contact (e.g.
contact from participants following triggering of a Level
2 action or clinician alert following a Level 3 action) was
considered timely and appropriate, and clinicians re-
ported that they did not think any concerning symptoms
had been ‘missed’ by participants who received ePRO
advice to contact them. In some cases, these directly in-
formed the clinical management of patients. On several
occasions, for example, clinicians’ arranged GP or hos-
pital appointments for patients who had been advised to
call them. The majority of ePRO-initiated clinician
contact (e.g. contact from participants following trigger-
ing of a Level 2 action or clinician alert following a Level
3 action) was considered timely and appropriate:
Clinician 1: “I’m not sure he would have thought to
ring us, as his first port of call. And we were able to
sort of triage what the problem was and make sure
he spoke to the right person.”
Similar to patients, clinicians regarded the ePRO sys-
tem as useful for providing patients with reassurance
about how to manage their symptoms appropriately.
Additionally, clinicians found the ePRO symptom-
reports provided a valuable insight into understand-
ing participants’ experiences of recovery and moni-
toring symptoms in the context of ongoing recovery.
This insight was found to be particularly relevant for
facilitating telephone consultations with participants:
Clinician 2: “I found [the ePRO symptom-report
system] particularly useful on the phone because
when you’re speaking to a patient on the phone, all
the visual cues are lacking… you can run through all
of the things you’d normally speak to them about,
but then you can also say, oh…your such and such
[symptom-report on the ePRO system] was a little
bit concerning. And it can help to guide the
conversation but, it can also make sure that things
aren’t overlooked, because often, particularly in a
telephone conversation they can be.”
The CNS team commented that being able to access
ePRO symptom reports via the hospital EHRs was appro-
priate and useful. However, they acknowledged that use of
the ePRO system may be influenced by existing complex-
ities of hospital systems and limited access to computers:
Fig. 4 Frequency of Level 1 self-management advice generated by timepoint. 1Higher scores indicate worse symptoms. 2Higher scores in physical
function indicate better physical function
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Clinician 1: “It’s just like in clinic sometimes we
can’t always access a computer to look at [patient
results] before [patients] come in.”
Technical performance
Between 25/08/2017 and 15/03/2018, there was one inci-
dent of unplanned downtime between the ePRO system
and EHRs which resulted in clinicians being unable to
view ePRO symptom reports via EHRs. There was one
incident where a participant was unable to access the
ePRO system at baseline due to an administrative error.
Both issues were resolved within one and 5 days respect-
ively. Due to a University of Bristol IT server update
there was a five-day period of downtime in the partici-
pant email/text message reminder system. This resulted
in four participants having their reminder messages de-
layed by up to 5 days.
Piloting of potential outcome measures for a main trial
Completed FACT-G and EQ-5D questionnaires were
returned by 19 (66%) and 20 (69%) of participants at
week four post-discharge and 15 (52%) at week eight.
Fifteen (52%) health resource use forms were returned.
Discussion
The findings from this pilot study indicate that this
novel electronic system for the real-time, remote moni-
toring of symptoms and problems in patients recovering
from cancer-related UGI surgery is feasible and accept-
able to both patients and clinicians. Adherence to the
routine symptom report completions was good and pa-
tients described the ePRO system as reassuring and a
valuable support to the self-management of their symp-
toms, particularly when they were uncertain if those
symptoms required clinical intervention. Clinicians
regarded the system as a useful adjunct to the routine
clinical management of patients. The system detected
symptoms indicative of adverse events, including numer-
ous concerning symptoms that prompted contact with
HCPs. Appropriate alerts were provided to clinicians
and the system identified severe complications associ-
ated with hospital re-admissions. The system also
worked well in a less-experienced hospital that had not
been involved in the developmental work. It is therefore
recommended that the ePRO system is further evaluated
in the context of a clinical effectiveness study to inform
full implementation into the healthcare system.
Studies of other ePRO systems have typically focused
on evaluating the feasibility of PRO data collection
alone, rather than their real-time integration of ePRO
data into routine post-discharge clinical management
[41–44]. A recent RCT of 344 patients in the
Netherlands concluded that use of a “personalised” e-
Health programme improved rates of return to normal
activities compared to usual care following general or
gynaecological surgery for benign conditions [45]. This
programme was not integrated into hospital EHR and
alerts to contact a health professional were sent only to
patients reporting a delayed recovery, and not to clini-
cians. Patient feedback was based only on data relating
to resumption of daily activities inputted by patients a
priori and tailored only to patient demographic factors
(e.g. surgical procedure, sex). The nature and severity of
symptoms experienced by patients was also not mea-
sured. The functionality to provide individually-tailored
advice based on symptom severity has been identified as
particularly important for the effectiveness of ePRO sys-
tems [46–48]. Similarly, the incorporation of clinician
alerts to ePRO systems can increase clinician involve-
ment in patient care and improve patient outcomes [25,
29]. However, some clinicians may not act upon alerts
generated by symptom-report systems [15], possibly due
to perceived disruption to usual workflow pathways [49]
or uncertainty over how to respond. To overcome these
issues, the ePRO surgery system reported in this study
not only alerts clinicians to concerning symptoms but
also provides guidance about responding to alerts and
has been developed with clinician input and incorpor-
ation into existing clinical pathways [21, 50, 51].
ERAS protocols lack standardisation around the tim-
ing and nature of clinical follow-up for patients follow-
ing cancer-related UGI surgery [52], with most clinical
contact occurring shortly after hospital discharge. How-
ever, in the current study, nearly half of all self-
management advice and advice to contact an HCP was
triggered in the latter period of recovery, up to 2 months
post-discharge. This information is useful to inform as-
sessment time points in a future RCT. It also highlights
an unmet healthcare need for the routine monitoring of
symptoms and the provision of advice after the acute
phase of patients’ recovery has passed. This study sup-
ports previous research indicating that it would be bene-
ficial to extend current ERAS protocols to encompass
the real-time monitoring of symptoms over a prolonged
period post-discharge [53].
In current practice, patients must accurately recall
relevant symptom-management information after their
discharge from hospital, which is generally delivered ver-
bally prior to treatment [54]. Recall may be impaired by
pain, fatigue, sleep deprivation [55] and cognitive dys-
function associated with critical care [56]. ePROM plat-
forms that systematically deliver individually-tailored
patient information have been associated with increased
information retention [57] and improved patient out-
comes [54, 58, 59]. Patients reported that the capacity
for the ePRO surgery system to monitor symptoms in
real-time and provide individually tailored advice on de-
mand enabled them to proactively and promptly manage
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their symptoms. The benefit and impact of this can fur-
ther be investigated within a main trial. In addition, cli-
nicians perceived a key advantage of the ePRO surgery
system to be the automated signposting of patients ex-
periencing problems to appropriate sources of health-
care. Clinicians did, however, identify potential barriers
to using the ePRO surgery system relating to integration
with hospital IT systems and EHR such as periods of
system downtime, replicating findings from other studies
[42, 49, 50, 60, 61]. For successful implementation in
clinical practice, developers of ePRO systems should en-
sure enough time and resources are dedicated to IT inte-
gration and ongoing support of live systems. Widespread
adoption of hospital-integrated ePRO systems is also
dependent upon patients having access to IT resources
at home. Approximately one fifth of patients approached
to take part in this study were not eligible because they
did not have access to a computer, laptop, mobile device
or the internet at home. This reflects internet usage
trends of UK households of those aged 65 and over [62].
Incorporating electronic systems into usual care path-
ways will require attention to providing additional moni-
toring of patients who are unable to use the systems.
The ePRO surgery system has been developed and
tested in a diverse group of patients. Mixed methods
were used to evaluate system functioning, adherence to
the study protocol, quality and completeness of data and
patients’ and clinicians’ views towards acceptability of
using the system alongside usual care. Symptom self-
report items originated or were informed by established,
validated measures used widely in studies of cancer pa-
tients. Participant refusal rates are in keeping with other
similar pilot studies [63] and studies of surgical patients
[64–66] and likely reflect in part how unwell participants
were feeling soon after major cancer surgery when they
were approached about recruitment to the study. It is
possible that patients who declined to participate may
have been feeling more unwell than those who took part.
However, patients must have reached a certain stage in
their recovery to have been considered by the healthcare
team as fit to be discharged, which is the point at which
patients were approached about participation. Further-
more, there did not appear to be any major differences
between patients who did and did not take part. The im-
pact of the timing of approaching patients and how to
safely monitor patients who decline to use the ePRO sys-
tem are important points to consider should the system
be implemented in routine clinical practice in the future.
Self-report completion rates and adherence to the ePRO
surgery system protocol were good, demonstrating that
weekly completion of the ePRO symptom-report and
duration of follow-up period were feasible and accept-
able. Participants received weekly and end of study data-
collection telephone interview from a researcher. While
these calls were not intended to discuss patients’ symp-
toms or provide advice regarding managing or seeking
treatment for problematic symptoms, it is possible that
receiving this weekly contact may have influenced ePRO
questionnaire completion rates. While several partici-
pants withdrew from the study because they felt too un-
well, this was expected due to the nature of the patient
group and the major surgery they had experienced. Data
completion was lowest at the earliest timepoint post-
discharge when patients were likely to be experiencing
the most frequent and severe symptoms. It is important
that consideration is given to instances when patients
feel too unwell to access the system. It may therefore be
beneficial to incorporate a mechanism in the system
whereby non-response at critical time points is regarded
as an indicator of potentially concerning symptoms and
a clinician alert is triggered. Clinicians at Centre 2 were
unable to access patients’ symptom reports via EHRs,
preventing pooling of data with that from Centre 1,
which may have limited clinicians’ engagement with the
ePRO system. There are also further refinements that
may improve the system’s performance, including re-
moving the pre-discharge Level 3 alert for symptoms in-
dicative of a complication, and amending the wording of
symptom-report items to ensure symptoms that have
already been resolved or are due to unrelated underlying
conditions do not trigger clinician alerts.
Conclusion
A real-time, hospital-integrated symptom monitoring
system has been developed to optimise the prompt and
effective management of symptoms and complications
experienced by patients after discharge following abdom-
inal cancer-related surgery. Following the findings from
this pilot study indicating that the ePRO surgery system
is feasible and acceptable to patients and clinicians, a de-
finitive RCT to evaluate the impact of the system on pa-
tients’ physical wellbeing is warranted.
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